Navarre (Spain) government publishes prostheses catalogue
This article was originally published in Clinica
The Navarre health authority (Spain) has published its reimbursement catalogue for orthoprostheses. The catalogue appears as part of statutory decree 226/1994 in the region's official journal (December 21st) and includes suitable revision times for each prosthesis as well as the financial details of reimbursement.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.